Personalized Stem Cells, Inc. proceeds with FDA approved stem cell trial for knee osteoarthritis with new safety precautions amid COVID-19 pandemic.
Personalized Stem Cells, Inc. peer-reviewed paper published in the Journal of Translational Medicine supporting stem cell therapy for COVID-19 patients.
La Jolla native Dr. Bob Harman is applying his expertise in the veterinary and biotech fields to developing a stem cell treatment for COVID-19.
Personalized Stem Cells Incorporated (PSC) in Poway said the therapy could reduce the most serious complications of the infection in the lungs.
As CEO of Personalized Stem Cells, Inc. in Poway, Dr. Harman is involved in the company’s quest to have the Food & Drug Administration (FDA) fast-track its Investigational New Drug application for the treatment of COVID-19 patients with stem cells.
Donations needed to ramp up stem cell production to provide treatments for COVID-19 patients.
CoronaStem 1 Trial – Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients
Personalized Stem Cells, Inc. (PSC) and its parent company, VetStem Biopharma, have filed an expedited review request for an Investigational New Drug (IND) application with the FDA for the treatment of COVID-19 patients with stem cells. The first trial is named...
Personalized Stem Cells, Inc. and Calidi Biotherapeutics collaborate to rapidly bring a stem cell therapy into clinical trials for COVID-19 patients.
Personalized Stem Cells Chief Scientific Officer, Dr. Robert Harman, Recently Presented at Trauma Conference
Personalized Stem Cells, Inc. recently attended and presented at the Cellular Therapies and Transfusion Medicine in Trauma and Critical Care conference.
Personalized Stem Cells, Inc. was a primary sponsor of an event put on by the Arthritis Foundation and hosted by Dr. Steven Sampson and Dr. Danielle Aufiero of the Orthohealing Center in Los Angeles, California.